Successful development of nanobodies for the clinic requires a thorough understanding of their germline, CDRs, and potential development liabilities.
Nanobody characteristics such as high stability, and specificity have led to their fusion with other proteins for therapeutic and diagnostic purposes.
Camelid antibodies exhibit unusual characteristics that provide a myriad of potential applications in research and therapeutics.
Whether you're a CRO making customer deliveries, a start-up advancing towards IND, or an established biopharma supporting multiple programs at once, Affinity supports every team, at every step, on a single platform, for a single price.